An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.

Source:http://linkedlifedata.com/resource/pubmed/id/16124422

Download in:

View as

General Info

PMID
16124422